Search

everythinglearnresearchcommunity

for

Search:↓

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

The treatment was effective and tolerable for advanced gastric cancer.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Nab-paclitaxel is as effective as cisplatin but safer for early-stage cervical cancer treatment.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Royal jelly can protect the heart from damage caused by paclitaxel.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

PLD is an effective and safer alternative for treating breast cancer.

Paclitaxel chemotherapy causes premature aging and damage to hair follicles, potentially leading to permanent hair loss.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Low-intensity ultrasound may prevent hair loss during taxane chemotherapy.

Taxane chemotherapy can cause permanent hair loss by damaging hair follicles and altering their DNA.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.